title: [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 2. Antiphospholipid syndrome].
authors.affiliation: Department of Medicine II, Hokkaido University Graduate School of Medicine, Japan.
authors.forename: Shinsuke
authors.initials: S
authors.lastname: Yasuda
mesh_terms: D000026:Abortion, Habitual / Q000517:prevention & control; D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants / Q000008:administration & dosage; D016736:Antiphospholipid Syndrome / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D001241:Aspirin / Q000008:administration & dosage; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011247:Pregnancy; D011248:Pregnancy Complications; D055502:Secondary Prevention; D013927:Thrombosis / Q000188:drug therapy / Q000517:prevention & control; D053482:beta 2-Glycoprotein I / Q000276:immunology
chemical_list: D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D053482:beta 2-Glycoprotein I; D006493:Heparin; D001241:Aspirin